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Abstract
Carica papaya (papaya) fruits are available throughout the world and it is well accepted 
as food or as a quasi-drug. Aqueous papaya leaves extract have been used as treatment for 
dengue fever. This prompted us to carry out the docking study on these nine selected ligands 
(phyto-constituents of papaya) which are carpaine, dehydrocarpaine I and II, cardenolide, 
p-coumaric acid, chlorogenic acid, caricaxanthin, violaxanthin and zeaxanthin. These phyto-
constituents were evaluated on the docking behaviour of dengue serotype 3 RNA-dependent 
RNA polymerase (RdRp);  influenza A (H1N9) virus neuraminidase (NA); chikungunya virus 
glycoprotein (E3-E2-E1) and  chikungunya virus non-structural protein2 (nsP2) protease 
using Discovery Studio Version 3.1. In addition, molecular physicochemical, drug-likeness, 
ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) and TOPKAT 
(Toxicity Prediction by Komputer Assisted Technology) analyses were done. The molecular 
physicochemical analysis revealed that cardenolide and p-coumaric acid (2 ligands) complied 
with Lipinski’s rule of five. Dehydrocarpaine II, cardenolide, caricaxanthin, violaxanthin and 
zeaxanthin all the five ligands were predicted to have plasma protein binding (PPB) effect. 
Docking studies and binding free energy calculations revealed that p-coumaric acid exhibited 
very least binding energy irrespective of its target protein. Hence, the results of this present 
study exhibited the potential of these nine ligands as antiviral agent.
Introduction
Carica papaya Linn is commonly known as 
papaya. It is well known for its food and nutritional 
values and moreover it is one among the popular fruits 
of the world. It is also called as “fruit of a common 
man”, owing to its high nutritive value and moreover 
it’s available for reasonable price throughout the 
world (Krishna et al., 2008). The fruit, flower, seed, 
leaf, bark and root of papaya tree are known to posses 
many biological active compounds, in which alkaloid 
is an important group of interest. For example, 
carpaine (alkaloid) from papaya leaf has been shown 
to have antiprotozoal, anthelmintic, antiplasmodial 
(Julianti et al., 2014) and antithrombocytopenic 
activity (Zunjar et al., 2016). Similarly, danielone 
from papaya fruit has been reported to have antifungal 
activity against Colletotrichum gloeosporioides 
(Yogiraj et al., 2014). 
Various parts of papaya have been utilized in 
traditional medicine in different parts of the world. 
For instance, daily consumption of green papaya 
leaves and as well as herbal infusion have been 
reported in some areas of Indonesia as means for 
preventing malaria disease (Julianti et al., 2014). 
Similarly aqueous papaya leaves extract have been 
used as treatment for dengue fever, which help the 
patient to increase platelets, white blood cells and 
neutrophil counts (Ahmad et al., 2011). In other 
report, flavonoid from papaya has been shown to 
inhibit viral non structural 2B and 3 (NS2B-NS3) 
protease complex and thereby prevents dengue 2 viral 
(DENV-2) assembly using molecular docking study 
(Senthilvel et al., 2013). This prompted us to carry 
out the docking study on these nine selected ligands 
(phyto-constituents of papaya) which are carpaine, 
dehydrocarpaine I and II, cardenolide, p-coumaric 
acid, chlorogenic acid, caricaxanthin, violaxanthin 
and zeaxanthin. These phyto-constituents were 
evaluated on the docking behaviour of dengue 
serotype 3 RNA-dependent RNA polymerase 
(RdRp);  influenza A (H1N9) virus neuraminidase 
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(NA); chikungunya virus glycoprotein (E3-E2-E1) 
and  chikungunya virus non-structural protein2 
(nsP2) protease with investigation on the enzymes 
putative binding sites using Discovery Studio 
Version 3.1. Therefore, the present study aims to 
determine the nine Carica papaya phyto-constituents 
as antiviral agent especially against dengue, influenza 
and chikungunya viruses using molecular docking 
method. 
        
Materials and Methods
Ligand preparation 
Chemical structures of the ligands i) carpaine 
(CID442630); ii) dehydrocarpaine I (HMDB30271); 
iii) dehydrocarpaine II (HMDB30273); iv) 
cardenolide (Chemspider ID19954501); v) 
p-coumaric acid (CID637542); vi) chlorogenic 
acid (Chemspider ID1405788); vii) caricaxanthin 
(Chemspider ID4444647); viii) violaxanthin 
(Chemspider ID395237) and ix) zeaxanthin 
(Chemspider ID444421) were retrieved from PubMed 
(www.pubmed.com) compound, human metabolome 
(www.hmdb.ca/metabolites) and Chemspider (www.
chemspider.com) compound database  respectively.
Target protein identification and preparation
The three dimensional structures of the dengue 
RNA-dependent RNA polymerase (RdRp) (PDB 
ID: 3VWS with resolution of 2.1 Å), influenza 
neuraminidase (PDB ID: 1L7F with resolution of 
1.8 Å), chikungunya glycoprotein (PDB ID: 3N44 
with resolution of 2.35 Å) and chikungunya nsP2 
protease (PDB ID: 3TRK with resolution of 2.4 Å) 
were obtained from the Research Collaborator for 
Structural Bioinformatics (RCSB) Protein Data 
Bank (Anonymous, www.rcsb.org). A chain of all of 
the proteins (except for chikungunya glycoprotein, 
where A, B and F) was pre-processed separately by 
deleting ligand, as well as the crystallographically 
observed water molecules (water without hydrogen 
bonds).
Molecular descriptors calculation
Molinspiration online database was used for the 
nine selected ligands to calculate thirteen descriptors 
(www.molinspiration.com) which are log P, polar 
surface area, molecular weight, number of atoms, 
number of O or N, number of OH or NH, number 
of rotatable bonds, volume, drug likeness including 
G protein coupled receptors (GPCR) ligand, ion 
channel modulator, kinase inhibitor and nuclear 
receptor ligand, and the number of violations to 
Lipinski’s rule. 
ADMET and TOPKAT analysis
Both of ADMET (Absorption, Distribution, 
Metabolism, Excretion and Toxicity) and TOPKAT 
(Toxicity Prediction by Komputer Assisted 
Technology) tests were performed using Discovery 
Studio® 3.1 (Accelrys, San Diego, USA). ADMET 
analysis was performed using human intestinal 
absorption (HIA), aqueous solubility (AS), blood brain 
barrier (BBB), cytochrome P450 2D6 (CYP2D6), 
plasma protein binding (PPB) and hepatotoxicity 
(HT) descriptors. As for the TOPKAT analysis, 
aerobic biodegradability (AB), Ames mutagenicity 
(AM), ocular irritancy (OI), skin irritancy (SI) , skin 
sensitization (SS) and oral toxicity in rat (LD50 in g/
Kg of body weight) descriptors were used.
Docking studies
Docking studies were carried out on the 
crystal structures of dengue RNA-dependent RNA 
polymerase (RdRp), influenza neuraminidase, 
chikungunya glycoprotein and chikungunya nsP2 
protease retrieved from Protein Data Bank using 
the CDOCKER protocol under the protein-ligand 
interaction section in Discovery Studio® 3.1 
(Accelrys, San Diego, USA). In general, CDOCKER 
is a grid-based molecular docking method that 
employs CHARMM force fields. A protein was firstly 
held rigid while the ligands were allowed to flex 
during the refinement. Two hundred random ligand 
conformations were then generated from the initial 
ligand structure through high temperature molecular 
dynamics followed by random rotations, refinement 
by grid-based (GRID I) simulated annealing, and 
a final grid-based or full force field minimisation 
(Wu et al., 2003). In this experiment, the ligand was 
heated to a temperature of 700 K in 2000 steps and 
the cooling steps were set in 5000 steps to 300 K with 
the grid extension set to 10 Å.  Hydrogen atoms were 
added to the structures and all ionisable residues were 
set at their default protonation state at a neutral pH. 
For each ligand, top ten ligand binding poses were 
ranked according to their CDOCKER energies, and 
the predicted binding interactions were then analysed 
from which the best among the ten ligand binding 
poses was chosen and carried out in situ ligand 
minimization using standard protocol.
Results 
Molecular descriptors analysis
Violation of zero will be the main target compound 
which was observed for cardenolide and p-coumaric 
acid suggesting that these compounds complied 
very well with the Lipinski’s rule of five. However, 
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carpaine, dehydrocarpaine I and II and chlorogenic 
acid showed one violation and caricaxanthin, 
violaxanthin and zeaxanthin showed two violations 
as shown in Table 1. Similarly in the present study 
only one ligand (cardenolide) showed active score 
(>0) towards all the six descriptors (except kinase 
inhibitor), whereas rest of ligands exhibited active 
to moderate active scores. Interestingly none of the 
ligand that shown inactive score (<-5.0), as shown in 
the Table 2.
ADMET and TOPKAT analysis
Table 3 shows the ADMET profile of the nine 
ligands, wherein cardenolide showed very high blood 
brain barrier (BBB) penetration effect compared to 
that of other ligands. Dehydrocarpaine II, cardenolide, 
caricaxanthin, violaxanthin and zeaxanthin all the 
five ligands were predicted to have plasma protein 
binding (PPB) effect. The toxicity profile of nine 
ligands as depicted in Table 4 all the ligands exhibited 
degradable nature towards aerobic biodegradability 
Table 1. Molecular physicochemical descriptors analysis of nine ligands 
using Molinspiration online software tool
a Octanol-Water partition coefficient, b Polar surface area, c Number of non 
hydrogen atoms, d Molecular weight, e Number of hydrogen bond acceptors [ 
O and N atoms], f Number of hydrogen bond donors [ OH and NH groups], 
g Number of Rule of 5 violations, h Number of rotatable bonds, i Molecular 
volume.
Table 2. Drug-likeness property analysis of 9 ligands using Molinspiration 
online software tool
*GPCR- G Protein coupled receptors
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effect. All of the ligands were predicted to have 
ocular irritancy effect in human. 
Molecular docking study
The docking studies and binding free energy 
calculations reported in Table 5A show that 
violaxanthin had the highest interaction energy 
(-59.17 kcal/mol) with that of dengue RNA-dependent 
RNA polymerase (RdRp). In contrast, p-coumaric 
acid showed the least interaction energy (-22.39 
kcal/mol) compared to other ligands. Interestingly 
four ligands (carpaine, dehydrocarpaine I and II 
and cardenolide) exhibited interaction with Thr413 
amino acid residue of dengue RNA-dependent RNA 
polymerase (RdRp) as shown in Table 5A. As for the 
docking studies and binding free energy calculations 
with influenza neuraminidase, violaxanthin exhibited 
the highest interaction energy (-53.54 kcal/mol) 
as shown in Table 5B. However, in the present 
study four ligands (carpaine, dehydrocarpaine I 
and II and cardenolide) fail to dock with influenza 
neuraminidase. Moreover, two ligands (violaxanthin 
Table 3. ADMET analysis of nine ligands
HIA-Human intestinal absorption, AS- Aqueous solubility, BBB-Blood brain barrier, PPB-Plasma 
protein binding, CYP2D6- cytochrome P450 2D6, HT-hepatotoxicity, L-Level, F-False and T-True.] 
*(0-good; 1-moderate; 2-poor and 3-very poor) ;**(0-extremely low; 1-very low; 2-low; 3-good; 
4-optimal; 5-too soluble and 6-warning);***(0-very high penetrate; 1-high; 2-medium; 3-low and 
4-undefined)
Table 4. Toxicity prediction analysis of nine ligands
AB*- Aerobic biodegradability; AM**- Ames mutagenicity; OI#- Ocular irritancy; SI##- Skin 
irritancy; SS♦- Skin sensitization and Oral toxicity▲- Oral toxicity in rat (LD
50
 in g/Kg of 
body weight-rat)
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and zeaxanthin) showed interaction with Glu227 
amino acid residue of influenza neuraminidase. The 
docking studies and binding free energy calculations 
reported in Table 5C show that violaxanthin  had the 
Table 5 A. The interaction energy analysis of nine ligands 
with that of dengue serotype 3 RNA-dependent RNA 
polymerase (RdRp) using Discovery Studio® 3.1
■ Pi-Sigma interaction, ♦ Pi-+ interaction
Table 5 B. The interaction energy analysis of nine ligands 
with that of influenza A (H1N9) virus neuraminidase (NA) 
using Discovery Studio® 3.1
highest interaction energy (-52.82 kcal/mol) with that 
of chikungunya glycoprotein. However, in the present 
study five ligands (carpaine, dehydrocarpaine I and 
II, cardenolide and chlorogenic acid) fail to dock 
with chikungunya glycoprotein. Interestingly three 
ligands (caricaxanthin, violaxanthin and zeaxanthin) 
exhibited interaction with Asn263 amino acid residue 
of chikungunya glycoprotein B chain. As for the 
docking studies and binding free energy calculations 
*F- Fails to dock, ◊+-Pi interaction
Table 5 C. The interaction energy analysis of nine ligands 
with that of chikungunya virus glycoprotein (E3-E2-E1) 
using Discovery Studio® 3.1
F*- Fails to dock, ◊- +-Pi interaction
Table 5 D. The interaction energy analysis of nine ligands 
with that of chikungunya virus non-structural protein2 
(nsP2) protease using Discovery Studio® 3.1
F*- Fails to dock, ◊ +-Pi interaction
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with chikungunya nsP2 protease, p-coumaric acid 
showed the least interaction energy (-22.31 kcal/
mol) as shown in Table 5D. However, in the present 
study four ligands (carpaine, dehydrocarpaine I and 
II and cardenolide) fail to dock with chikungunya 
nsP2 protease. Two ligands (p-coumaric acid and 
chlorogenic acid) exhibited interaction with Lys1239 
amino acid residue of chikungunya nsP2 protease as 
shown in Table 5D.
Discussion
Natural products have been serving as a main 
source of potential drugs. Recently, four natural 
product derivatives have been approved as an antiviral 
drug out of 138 drugs approved up to 2014 (Newman 
and Cragg, 2016) and which actually encourages 
more studies and research in natural product drug 
discovery programme. Interestingly, some proteolytic 
viral enzymes namely viral polymerase, integrase and 
reverse transcriptase serves as target for developing 
new antiviral agents. Because these enzymes, plays 
vital role in viral replication and assembly of the 
mature viral particle (Mishra et al., 2013). Searching 
for available foods/food products is still another wise 
strategy to develop specific inhibitors against these 
viral enzymes. Carica papaya fruits are available 
throughout the world and it is well accepted as food 
or as a quasi-drug (Kovendan et al., 2012). In the 
present study, we carried out molecular docking 
analysis on Carica papaya constituents as antiviral 
agent against i) dengue serotype 3 RNA-dependent 
RNA polymerase (RdRp); ii) influenza A (H1N9) 
virus neuraminidase (NA); iii) chikungunya virus 
glycoprotein (E3-E2-E1) and iv) chikungunya virus 
non-structural protein2 (nsP2) protease. Bhatt and 
co-workers (2013) reported that over half (50%) of 
the world’s population is at high risk for infection by 
dengue virus. Reiner and co-workers (2014) reported 
that force of infection (FoI) in the case of dengue 
virus (DENV) has been observed high for dengue 
serotype 3 and 4, when compare to that of dengue 
serotype 1 and 2. RNA-dependent RNA polymerase 
(RdRp) is an enzyme which catalyzes the replication 
of RNA from an RNA template. It is a vital protein 
encoded in the genomes of all RNA containing 
viruses including Dengue virus and its activity is 
essential for maintaining viral cycle and replication 
(Bhattacharya et al., 2008). In general, RdRp 
enzymes family had three conserved sub-domains 
such as palm, fingers and thumb. RdRp from dengue 
virus serotype 3 (DENV-3) has been reported to be 
new target for developing novel antiviral compounds 
against dengue fever (Hansen et al., 1997 and Ariza 
et al., 2014). In the present study, all nine ligands had 
docked well with RNA-dependent RNA polymerase 
(RdRp) of dengue serotype 3 viral enzyme. Yogiraj 
and co-workers (2014) had summarized four pilot 
studies on use of Carica papaya as therapeutic 
agent for dengue fever management. Similarly, 
Senthilvel and co-workers (2013) had reported that 
both p-coumaric acid and chlorogenic acid inhibits 
viral non structural 2B and 3 (NS2B-NS3) protease 
complex. The two above mentioned reports were in 
good agreement with the present study. 
Influenza is commonly called as flu, which is a 
serious infectious disease caused by influenza virus. 
At present much attention has been gained among 
the researchers to develop inhibitors of influenza 
neuraminidase (NA), because it serves as a main drug 
target for both prophylaxis and treatment for influenza 
infection. Shaukat and co-workers (2011) reported 
that papaya leaves extract at low concentrations 
(2 to 8 µg/ml) fails to inhibit influenza (H7N3) 
virus replication. Similarly in the present study 
three papaya alkaloids (carpaine, dehydrocarpaine 
I and II) fail to dock with influenza neuraminidase 
(NA). Chlorogenic acid has been reported to inhibit 
influenza A (H5N1) virus neuraminidase (Luo et al., 
2011) and influenza A (H7N9) virus neuraminidase 
respectively (Liu et al., 2015). The p-coumaric 
acid has been reported to have anti-influenza viral 
activities in mice model, by prolonging survival rates 
and reducing virus titers in bronchoalveolar lavage 
(BAL) fluids (Pie et al., 2016). The above mentioned 
reports were in good agreement with the present 
study.
Chikungunya is an infectious disease caused 
by chikungunya virus. Aedes albopictus and Aedes 
aegypti are two vectors responsible for chikungunya 
virus transmission. Kovendan and co-workers (2012) 
reported that Carica papaya methanolic leaf extract 
has shown good larvicidal and pupicidal activity 
against the chikungunya vector (Aedes aegypti). 
Chlorogenic acid has been reported to have antiviral 
activity against chikungunya virus (Buhner, 2013).
Conclusion
In the present study, it was found that three ligands 
(caricaxanthin, violaxanthin and zeaxanthin) has the 
potential to dock with all the four targeted proteins, 
whereas four ligands (carpaine, dehydrocarpaine 
I and II and cardenolide) failed to dock and bind 
with the three targeted proteins. Interestingly all 
the nine ligands showed the potential to dock with 
dengue serotype 3 RNA-dependent RNA polymerase 
(RdRp), which again demonstrate the use of papaya 
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as therapeutic agent for dengue fever management. 
Hence, it is strongly suggested that the results of 
this present study has paved better understanding of 
these nine ligands of Carica papaya Linn as potential 
antiviral agent.
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